/주식/INCR
INCR

INCR

USD

Intercure Ltd. Ordinary Shares

$1.480+0.014 (0.969%)

실시간 가격

Healthcare
Drug Manufacturers - Specialty & Generic
이스라엘

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.466

고가

$1.490

저가

$1.390

거래량

0.00M

기업 기본 정보

시가총액

69.8M

산업

Drug Manufacturers - Specialty & Generic

국가

Israel

거래 통계

평균 거래량

0.02M

거래소

NGM

통화

USD

52주 범위

저가 $1.17현재가 $1.480고가 $3.72

AI 분석 리포트

마지막 업데이트: 2025년 4월 24일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

INCR: Intercure Ltd. Ordinary Shares - Analyzing Recent Moves & What Might Come Next

Stock Symbol: INCR Generate Date: 2025-04-24 13:18:38

Alright, let's break down what's been happening with Intercure, ticker symbol INCR, and see what the data might be telling us. Think of this as looking under the hood a bit to get a clearer picture.

What's the Buzz from the News?

We got one specific news item about a change at the top – Ehud Barak stepped down as Chairman, and Alexander Rabinovich took over back in February. Now, a leadership change like that can sometimes stir things up, but on its own, it's not necessarily good or bad. It's just... a change.

However, the analysis data provided points to something interesting: it flags the overall recent news sentiment as quite positive. It even mentions a "News-Driven Surge" tag. This suggests that while the chairman news is one piece, there might be other positive developments or general market sentiment around the company or its sector that's creating a favorable buzz. So, despite the single news item being neutral on its face, the vibe around INCR seems to be leaning positive according to the sentiment analysis.

Looking at the Chart: What's the Stock Been Up To?

Checking out the price history over the last few months, INCR has had a bit of a rough ride. Back in late January, it was trading around the $1.70s. It bounced around a bit, even spiking briefly in February, but generally, the trend has been downwards since then. It hit its recent low point around the $1.20 mark in early April.

But here's the twist: in the last couple of weeks, the stock has started to climb back up. It moved from those lows into the $1.30s and closed recently around $1.46. So, after a period of decline, we're seeing a bit of a bounce-back effort.

Now, let's compare this to the AI's crystal ball look. The AI predicts today will be pretty flat, maybe a tiny dip (-0.03%). But then, it sees things picking up, predicting gains of 1.65% the next day and 2.17% the day after that. It even throws out a potential target price around $1.65. This aligns with the recent upward nudge we've seen in the price action.

Putting It All Together: What Might This Mean?

Based on the positive news sentiment signals, the stock's recent move off its lows, and the AI predicting further upward movement in the very near term, the situation seems to lean towards a potentially positive outlook right now. It looks like the stock is trying to build some momentum after a tough stretch.

  • Potential Entry Consideration: If you were thinking about this stock, the data suggests that the current price area, around the recent close of $1.46, or perhaps on any small dip today, could be a point to consider. Why? Because it's near a suggested entry level from the analysis data ($1.46 is one) and it's where the AI expects the price to stabilize before potentially heading higher.
  • Potential Exit/Stop-Loss Consideration: Managing risk is always key. The AI's potential target is $1.65, and the analysis data suggests a take-profit level around $1.75. These could be areas to watch if the stock does move up – places where you might consider taking some gains. On the flip side, to protect against the price turning south again, the analysis suggests a stop-loss level around $1.31. This is below recent lows and acts as a point to potentially cut losses if the upward trend doesn't hold.

A Little Company Context

It's worth remembering that Intercure is primarily involved in the cannabis and biomed space. This sector can be quite volatile, sometimes reacting strongly to regulatory news or industry trends. Also, looking at the company details, it's a relatively small company with a market cap under $70 million and not a huge amount of trading volume on average. Small companies can sometimes make bigger moves, but they can also be riskier. The fundamental data also points to some challenges like negative growth, low return on equity, and higher debt, which are important long-term factors to keep in mind, even if short-term technicals or sentiment look positive.

So, the current picture seems to show a stock trying to turn things around, with some positive signals from sentiment and AI predictions, but it's operating in a potentially volatile sector and has some fundamental challenges.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

관련 뉴스

PR Newswire

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), announces today that Mr. Ehud Barak will step down as...

더 보기
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 4월 28일 오후 01:22

약세중립강세

60.0% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
가치
트레이딩 가이드

진입점

$1.45

익절

$1.55

손절

$1.31

핵심 요소

PDI 31.1이(가) ADX 13.6과 함께 MDI 28.8 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($1.46) 근처에 있어 잠재적인 매수 기회를 나타냅니다.
MACD 0.0156이(가) 신호선 0.0173 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기